(Q55463372)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Pieter Wesseling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

William Leenders

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Bob C Hamans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

An Claes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Arend Heerschap

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Judith W M Jeuken

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

21 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

626-634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

Angiogenesis in brain tumors; pathobiological and clinical aspects

23 January 2020

cites work

1 reference

Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

21 January 2018

1 reference

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

21 January 2018

1 reference

Magnetic resonance imaging-based detection of glial brain tumors in mice after antiangiogenic treatment

21 January 2018

1 reference

Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

Antiangiogenic therapy in malignant gliomas

21 January 2018

1 reference

Vessel normalization by VEGF inhibition. A complex story.

21 January 2018

1 reference

Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization.

21 January 2018

1 reference

Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option

21 January 2018

1 reference

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

21 January 2018

1 reference

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy.

21 January 2018

1 reference

Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression.

21 January 2018

1 reference

Angiogenesis in gliomas: imaging and experimental therapeutics

21 January 2018

1 reference

Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis.

21 January 2018

1 reference

Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis.

21 January 2018

1 reference

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.

21 January 2018

1 reference

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice

21 January 2018

1 reference

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

21 January 2018

1 reference

Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.2836

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21341272%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference